PTAB blocks Qiagen’s bid to invalidate diagnostics patent

20-07-2020

Muireann Bolger

PTAB blocks Qiagen’s bid to invalidate diagnostics patent

olm26250 / iStockphoto.com

Biotechnology company Qiagen has failed in its bid to stop diagnostics company HandyLab from retaining a patent for a diagnostic system, according to a decision issued by the US Patent Trial and Appeal Board on Tuesday, July 14. 


HandyLab, Qiagen, PTAB, Biotechnology, NeuMoDx, Becton, Dickinson & Co,, diagnostics, diagnostic system, patent, Delaware

LSIPR